Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132Dian Wang, Burton Eisenberg, George D. Demetri et al.|Annals of Surgical Oncology|2011Cited by 202